SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510964-23-000024
Filing Date
2023-05-15
Accepted
2023-05-15 16:05:09
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20230331.htm   iXBRL 10-Q 889275
2 EX-31.1 cvsi-2023331xex311.htm EX-31.1 9344
3 EX-31.2 cvsi-2023331xex312.htm EX-31.2 9320
4 EX-32.1 cvsi-2023331xex321.htm EX-32.1 4269
5 EX-32.2 cvsi-2023331xex322.htm EX-32.2 4238
  Complete submission text file 0001510964-23-000024.txt   4876975

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20230331.xsd EX-101.SCH 37631
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20230331_cal.xml EX-101.CAL 42063
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20230331_def.xml EX-101.DEF 178413
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20230331_lab.xml EX-101.LAB 507261
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20230331_pre.xml EX-101.PRE 321399
56 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20230331_htm.xml XML 606349
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 23921935
SIC: 2834 Pharmaceutical Preparations